Horizon Pharma plc Announces Poster Presentation on KRYSTEXXA® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017

Go back to Horizon Pharma plc Announces Poster Presentation on KRYSTEXXA® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017

Horizon Pharma (HZNP) PT Raised to $21 at Jefferies; Reiterates Buy

November 7, 2017 8:34 AM EST

Jefferies raised its price target on Horizon Pharma (NASDAQ: HZNP) to $21.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report.

Including the upside from the Q3 results and expected shift in operating expenses from Q3 to Q4, Jefferies raised... More